References
- Hanahan D., Weinberg R.A. Cell. 2000; 100: 57–70
- Bergers G., Benjamin L.E. Nat Rev Cancer. 2003; 3: 401–410
- Sonveaux P. Radiotherapy and Oncology 2008; 86: 300–313
- Brown J.M. Cancer Res. 1999; 59: 5863–5870
- D'Agnillo F., Chang T.M. Nat Biotechnol. 1998; 16: 667–671
- Burmeister M.A., Rempf C., Standl T.G., Rehberg S., Bartsch–Zwemke S., Krause T., Tuszynski S., Gottschalk A., Schulte am Esch J. Br J Anaesth. 2005; 95: 737–745
- Robinson M.F., Dupuis N.P., Kusumoto T., Liu F., Menon K., Teicher B.A. Artificial Cells, Blood Substitutes, and Biotechnology 1995; 23: 431–438
- Nozue M., Lee I., Manning J.M., Manning L.R., Jain R.K. J Surg Oncol. 1996; 62: 109–114
- McNeil C.J., Smith L.D., Jenkins L.D., York M.G., Josephs M.J. J Trauma. 2001; 50: 1063–1075
- Standl T., Freitag M., Burmeister M.A., Horn E.P., Wilhelm S., Am Esch J.S. J Vasc Surg. 2003; 37: 859–865
- Li T., Yu R., Zhang H.H., Wang H., Liang W.G., Yang X.M., Yang C.M. Artif Cells Blood Substit Immobil Biotechnol. 2006; 34: 175–188